Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) associated disease (COVID-19) outbreak seriously challenges globally all health care systems and professionals. Expert projections estimate that despite social distancing and lockdown being practiced, we have yet to feel the full impact of COVID-19. In this manuscript we provide guidance to prepare for the impact of COVID-19 pandemic on breast cancer patients and advise on how to triage, prioritize and organize diagnostic procedures, surgical, radiation and medical treatments.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Breast

Title: Breast (Edinburgh, Scotland)

Publisher: Elsevier BV

ISSN (Electronic): 1532-3080

ISSN (Print): 0960-9776

Publication date (Electronic): Apr 16 2020

Volume: 52

Affiliations

[1 ] Istituto Europeo di Oncologia, IRCCS, Department of Early Drug Development, Italy; University of Milano, Milano, Italy. Electronic address: giuseppe.curigliano@ieo.it.

[2 ] Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Portugal; Nova Medical School, Lisbon, Portugal.

[3 ] Iridium Kankernetwerk, Department of Radiation Oncology, Wilrijk-Antwerp, Belgium; University of Antwerp, Faculty of Medicine and Health Sciences, Wilrijk-Antwerp, Belgium.

[4 ] Breast Surgery, San Raffaele University and Research Hospital, Milano, Italy.

[5 ] Istituto Europeo di Oncologia, IRCCS, Department of Early Drug Development, Italy; University of Milano, Milano, Italy.

[6 ] Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.

[7 ] Service Interdisciplinaire de Cancérologie, Hopital Riviera-Chablais, Rennaz, Vaud, Geneva University Hospitals, Swiss Group for Clinical Cancer Research (SAKK), Switzerland.

[8 ] Medical University of Gdansk, Gdansk, Poland.

[9 ] Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Portugal.

Article

Publisher Item ID: S0960-9776(20)30093-X

DOI: 10.1016/j.breast.2020.04.006

PMC ID: 7162626

PubMed ID: 32334323

SO-VID: 80c5d9a7-d845-41fd-9526-b03ecc0219b6

History

Data availability:

Comments

Comment on this article

scite_

Cited by 92

See all cited by